🚀 VC round data is live in beta, check it out!

4DMedical Valuation Multiples

Discover revenue and EBITDA valuation multiples for 4DMedical and similar public comparables like UFP Technologies, MicroPort EP, AtriCure, Wandong Medical and more.

4DMedical Overview

About 4DMedical

4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.


Founded

2012

HQ

Australia

Employees

124

Financials (LTM)

Revenue: $5M
EBITDA: ($20M)

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

4DMedical Financials

4DMedical reported last 12-month revenue of $5M and negative EBITDA of ($20M).

In the same LTM period, 4DMedical generated ($7M) in gross profit, ($20M) in EBITDA losses, and had net loss of ($46M).

Revenue (LTM)


4DMedical P&L

In the most recent fiscal year, 4DMedical reported revenue of $4M and EBITDA of ($17M).

4DMedical expects next 12-month revenue of XXX and NTM EBITDA of XXX

See 4DMedical forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$5MXXX$4MXXXXXXXXX
Gross Profit($7M)XXX$4MXXXXXXXXX
Gross Margin(135%)XXX92%XXXXXXXXX
EBITDA($20M)XXX($17M)XXXXXXXXX
EBITDA Margin(369%)XXX(430%)XXXXXXXXX
EBIT Margin(437%)XXX(571%)XXXXXXXXX
Net Profit($46M)XXX($20M)XXXXXXXXX
Net Margin(862%)XXX(487%)XXXXXXXXX

Financial data powered by Morningstar, Inc.

4DMedical Stock Performance

4DMedical has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


4DMedical's stock price is $2.76.

See 4DMedical trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B-0.1%XXXXXXXXX$-0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

4DMedical Valuation Multiples

4DMedical trades at 286.8x EV/Revenue multiple, and (77.8x) EV/EBITDA.

See valuation multiples for 4DMedical and 15K+ public comps

EV / Revenue (LTM)


4DMedical Financial Valuation Multiples

As of March 26, 2026, 4DMedical has market cap of $2B and EV of $2B.

Equity research analysts estimate 4DMedical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

4DMedical has a P/E ratio of (34.0x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$2BXXX$2BXXXXXXXXX
EV (current)$2BXXX$2BXXXXXXXXX
EV/Revenue286.8xXXX382.1xXXXXXXXXX
EV/EBITDA(77.8x)XXX(88.9x)XXXXXXXXX
EV/EBIT(65.6x)XXX(66.9x)XXXXXXXXX
EV/Gross Profit(212.6x)XXX415.4xXXXXXXXXX
P/E(34.0x)XXX(80.1x)XXXXXXXXX
EV/FCF(75.1x)XXX(65.4x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified 4DMedical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

4DMedical Margins & Growth Rates

4DMedical's revenue in the last 12 month grew by 222%.

4DMedical's revenue per employee in the last FY averaged $0.0M.

4DMedical's rule of 40 is (147%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

4DMedical's rule of X is 187% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for 4DMedical and other 15K+ public comps

4DMedical Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth222%XXX47%XXXXXXXXX
EBITDA Margin(369%)XXX(430%)XXXXXXXXX
EBITDA Growth(28%)XXX17%XXXXXXXXX
Rule of 40—XXX(147%)XXXXXXXXX
Bessemer Rule of X—XXX187%XXXXXXXXX
Revenue per Employee—XXX$0.0MXXXXXXXXX
S&M Expenses to Revenue—XXX28%XXXXXXXXX
G&A Expenses to Revenue—XXX574%XXXXXXXXX
R&D Expenses to Revenue0%XXX15%XXXXXXXXX
Opex to Revenue—XXX915%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

4DMedical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
UFP TechnologiesXXXXXXXXXXXXXXXXXX
MicroPort EPXXXXXXXXXXXXXXXXXX
AtriCureXXXXXXXXXXXXXXXXXX
Wandong MedicalXXXXXXXXXXXXXXXXXX
AxogenXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

4DMedical M&A Activity

4DMedical acquired XXX companies to date.

Last acquisition by 4DMedical was on XXXXXXXX, XXXXX. 4DMedical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by 4DMedical

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

4DMedical Investment Activity

4DMedical invested in XXX companies to date.

4DMedical made its latest investment on XXXXXXXX, XXXXX. 4DMedical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by 4DMedical

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About 4DMedical

When was 4DMedical founded?4DMedical was founded in 2012.
Where is 4DMedical headquartered?4DMedical is headquartered in Australia.
How many employees does 4DMedical have?As of today, 4DMedical has over 124 employees.
Is 4DMedical publicly listed?Yes, 4DMedical is a public company listed on Australian Securities Exchange.
What is the stock symbol of 4DMedical?4DMedical trades under 4DX ticker.
When did 4DMedical go public?4DMedical went public in 2020.
Who are competitors of 4DMedical?4DMedical main competitors are UFP Technologies, MicroPort EP, AtriCure, Wandong Medical.
What is the current market cap of 4DMedical?4DMedical's current market cap is $2B.
What is the current revenue of 4DMedical?4DMedical's last 12 months revenue is $5M.
What is the current revenue growth of 4DMedical?4DMedical revenue growth (NTM/LTM) is 222%.
What is the current EV/Revenue multiple of 4DMedical?Current revenue multiple of 4DMedical is 286.8x.
Is 4DMedical profitable?No, 4DMedical is not profitable.
What is the current EBITDA of 4DMedical?4DMedical has negative EBITDA and is not profitable.
What is 4DMedical's EBITDA margin?4DMedical's last 12 months EBITDA margin is (369%).
What is the current EV/EBITDA multiple of 4DMedical?Current EBITDA multiple of 4DMedical is (77.8x).
What is the current FCF of 4DMedical?4DMedical's last 12 months FCF is ($21M).
What is 4DMedical's FCF margin?4DMedical's last 12 months FCF margin is (382%).
What is the current EV/FCF multiple of 4DMedical?Current FCF multiple of 4DMedical is (75.1x).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial